These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4438427)

  • 1. Therapy resistant depressions. Methodological problems. Contributions to methodical questions and animal-experimental aspects.
    Pichot P
    Pharmakopsychiatr Neuropsychopharmakol; 1974 Mar; 7(2):80-4. PubMed ID: 4438427
    [No Abstract]   [Full Text] [Related]  

  • 2. The psychiatrist attitudes and therapeutic means when faced with resistant depressions.
    Ginestet D
    Pharmakopsychiatr Neuropsychopharmakol; 1974 Jul; 7(4):194-8. PubMed ID: 4216905
    [No Abstract]   [Full Text] [Related]  

  • 3. Contributions to the definition of therapy-resistance and of the therapy-resistant depressions.
    Freyhan FA
    Pharmakopsychiatr Neuropsychopharmakol; 1974 Mar; 7(2):70-5. PubMed ID: 4438425
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapy possibilities for therapy-resistant depressions.
    Berner P; Kryspin-Exner K; Poeldinger W
    Pharmakopsychiatr Neuropsychopharmakol; 1974 Jul; 7(4):189-93. PubMed ID: 4614274
    [No Abstract]   [Full Text] [Related]  

  • 5. Description and classification of depressive disorders. Contributions for the definition of the therapy-resistance and of therapy resistant depressions.
    Sartorius N
    Pharmakopsychiatr Neuropsychopharmakol; 1974 Mar; 7(2):76-9. PubMed ID: 4438426
    [No Abstract]   [Full Text] [Related]  

  • 6. Predicting treatment responsiveness-resistiveness in a population of depressed patients.
    Levine J; Raskin A
    Pharmakopsychiatr Neuropsychopharmakol; 1974 Jul; 7(4):217-22. PubMed ID: 4445195
    [No Abstract]   [Full Text] [Related]  

  • 7. Measurement of drug effects in newly hospitalized depressives.
    Rockliff BW
    Dis Nerv Syst; 1971 Aug; 32(8):532-7. PubMed ID: 4937543
    [No Abstract]   [Full Text] [Related]  

  • 8. Thyroid-hormone enhancement of imipramine in nonretarded depressions.
    Wilson IC; Prange AJ; McClane TK; Rabon AM; Lipton MA
    N Engl J Med; 1970 May; 282(19):1063-7. PubMed ID: 4908885
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence-possibilities on therapy-resistant late depressions.
    Walcher W
    Pharmakopsychiatr Neuropsychopharmakol; 1974 Jul; 7(4):207-10. PubMed ID: 4614276
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapy-resistant depressions - a clinical classification.
    Lehmann HE
    Pharmakopsychiatr Neuropsychopharmakol; 1974 May; 7(3):156-63. PubMed ID: 4438433
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of postpsychotic depression with sertraline in patients with schizophrenia--own experience.
    Ros LT
    Neuropsychopharmacol Hung; 2006 Oct; 8(3):155-6. PubMed ID: 17211050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of melitracen and imipramine in treatment of depressed patients.
    Biros D; Schiele BC; Ferguson D
    Curr Ther Res Clin Exp; 1969 May; 11(5):289-95. PubMed ID: 4977401
    [No Abstract]   [Full Text] [Related]  

  • 13. Double blind clinical study comparing doxepin and imipramine in depression.
    Hasan KZ; Akhtar MI
    Curr Ther Res Clin Exp; 1971 Jun; 13(6):327-36. PubMed ID: 4996218
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of resistant depression.
    Kelly D
    Pharmakopsychiatr Neuropsychopharmakol; 1974 Jul; 7(4):199-204. PubMed ID: 4614275
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapy-resistant depressions: symptoms and syndromes. Contributions to symptomatology and syndromes.
    Heimann H
    Pharmakopsychiatr Neuropsychopharmakol; 1974 May; 7(3):139-44. PubMed ID: 4438432
    [No Abstract]   [Full Text] [Related]  

  • 16. [Introductory remarks: on the status of therapy with antidepressive agents].
    Coper H; Hippius H; Selbach H
    Arzneimittelforschung; 1969 Jun; 19():Suppl 5a:835+. PubMed ID: 4895490
    [No Abstract]   [Full Text] [Related]  

  • 17. Amoxapine and imipramine: a double-blind study in depressed patients.
    Sathananthan GL; Matz R; Thompson H; Gershon S
    Curr Ther Res Clin Exp; 1973 Dec; 15(12):919-22. PubMed ID: 4203576
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical aspects of resistance to imipramine therapy.
    Angst J; Baumann U; Hippius H; Rothweiler R
    Pharmakopsychiatr Neuropsychopharmakol; 1974 Jul; 7(4):211-6. PubMed ID: 4614277
    [No Abstract]   [Full Text] [Related]  

  • 19. [Manic state during the addition of lithium in the case of depression resistant to imipramine].
    Beck-Lie A Fat JR; Birkenhäger TK; Renes JW
    Ned Tijdschr Geneeskd; 2002 Nov; 146(45):2157-9. PubMed ID: 12474557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. To the antidepressive properties of lithium and its place in the group of antidepressive drugs.
    Náhunek K; Svestka J; Rodová A
    Act Nerv Super (Praha); 1971; 13(3):169-70. PubMed ID: 4939828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.